The role of RANK ligand inhibitor in Giant cell tumors

Date 01 October 2012
Event ESMO Congress 2012
Session Orphan tumors: An ideal niche for selective targeted therapies
Topics Anticancer agents
Biological therapy
Presenter Jean-Yves Blay
Authors J. Blay
  • University Claude Bernard Lyon I, Centre Léon Bérard, 69008 - Lyon/FR